Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergy Research Group, Inc.
Nutraceutical company reports 7% increase in revenue for second quarter
September 10th, 2003
Allergy Research Group, Inc., (ALRG) announced financial results for the second quarter ending June 30, 2003. ALRG recorded total revenue of $3,447,130 for the quarter, up 7% from 2002. The increase of $213,005 is primarily due to increased sales to distributors and increased demand at retail for current and new products. Total revenue for the first quarter 2003 was $3,448,762. "We are very encouraged by our ability to sustain our current level of sales," said CEO and chairman, Stephen A. Levine, PhD. Cost of sales decreased $43,653 to $1,990,480 for the quarter ended June 30, 2003, compared to $2,034,133 for the quarter ended...
Source: Biotech Week (2003-09-10)
|
